DK2785368T3 - Immunogen sammensætning, der omfatter panton-valentine-leukocidin (pvl)-afledte polypeptider - Google Patents
Immunogen sammensætning, der omfatter panton-valentine-leukocidin (pvl)-afledte polypeptider Download PDFInfo
- Publication number
- DK2785368T3 DK2785368T3 DK12854165.3T DK12854165T DK2785368T3 DK 2785368 T3 DK2785368 T3 DK 2785368T3 DK 12854165 T DK12854165 T DK 12854165T DK 2785368 T3 DK2785368 T3 DK 2785368T3
- Authority
- DK
- Denmark
- Prior art keywords
- panton
- pvl
- composition containing
- immunogen composition
- valentine leukocidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161566234P | 2011-12-02 | 2011-12-02 | |
| PCT/US2012/067483 WO2013082558A1 (en) | 2011-12-02 | 2012-11-30 | Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2785368T3 true DK2785368T3 (da) | 2019-05-27 |
Family
ID=48536149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12854165.3T DK2785368T3 (da) | 2011-12-02 | 2012-11-30 | Immunogen sammensætning, der omfatter panton-valentine-leukocidin (pvl)-afledte polypeptider |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10023848B2 (da) |
| EP (1) | EP2785368B1 (da) |
| JP (1) | JP6325452B2 (da) |
| KR (1) | KR101999299B1 (da) |
| AU (1) | AU2012345645B2 (da) |
| CA (1) | CA2857666C (da) |
| DK (1) | DK2785368T3 (da) |
| ES (1) | ES2728445T3 (da) |
| HR (1) | HRP20190907T1 (da) |
| LT (1) | LT2785368T (da) |
| RS (1) | RS58919B1 (da) |
| SI (1) | SI2785368T1 (da) |
| WO (1) | WO2013082558A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2785368T3 (da) | 2011-12-02 | 2019-05-27 | Integrated Biotherapeutics Inc | Immunogen sammensætning, der omfatter panton-valentine-leukocidin (pvl)-afledte polypeptider |
| DK3441474T3 (da) | 2013-06-18 | 2020-08-17 | Univ New York | Farmaceutiske sammensætninger indeholdende et muteret leukocidin e |
| US9815872B2 (en) | 2013-06-19 | 2017-11-14 | Integrated Biotherapeutics, Inc. | Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof |
| US9017698B2 (en) | 2013-09-25 | 2015-04-28 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9504743B2 (en) | 2013-09-25 | 2016-11-29 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9149522B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9149521B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| EP3057989A1 (en) * | 2013-10-17 | 2016-08-24 | ARSANIS Biosciences GmbH | Cross-reactive staphylococcus aureus antibody sequences |
| JP6620817B2 (ja) * | 2015-08-10 | 2019-12-18 | 株式会社微生物化学研究所 | 黄色ブドウ球菌不活化菌体とロイコシジンを混合したワクチン |
| CN107224575B (zh) * | 2017-03-06 | 2018-11-09 | 浙江海隆生物科技有限公司 | 奶牛金黄色葡萄球菌乳房炎亚单位疫苗的组合物及其制备方法和应用 |
| WO2019023341A1 (en) | 2017-07-27 | 2019-01-31 | Integrated Biotherapeutics, Inc. | IMMUNOGENIC COMPOSITION COMPRISING A MELTING PEPTIDE DERIVED FROM TOXOIDS OF SUPERANTIGENES |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US20100158871A1 (en) | 1999-08-30 | 2010-06-24 | David Stephen Terman | Sickled erythrocytes with antitumor molecules induce tumoricidal effects |
| US20050008633A1 (en) | 2003-05-19 | 2005-01-13 | Advanced Inhalation Research Inc. | Chemical and physical modulators of bioavailability of inhaled compositions |
| AR055580A1 (es) * | 2005-06-13 | 2007-08-29 | Nabi Biopharmaceuticals | Uso de leucocidina de panton valentine para el tratamiento y prevencion de infecciones por estafilococos |
| US7754225B2 (en) | 2006-07-20 | 2010-07-13 | Glaxosmithkline Biologicals S.A. | Method of protecting against staphylococcal infection |
| EP2388593A3 (fr) * | 2006-10-18 | 2012-01-18 | bioMérieux | Procédé de diagnostic in vitro des Staphylococcus aureus producteurs de PVL |
| DK2785368T3 (da) | 2011-12-02 | 2019-05-27 | Integrated Biotherapeutics Inc | Immunogen sammensætning, der omfatter panton-valentine-leukocidin (pvl)-afledte polypeptider |
-
2012
- 2012-11-30 DK DK12854165.3T patent/DK2785368T3/da active
- 2012-11-30 EP EP12854165.3A patent/EP2785368B1/en active Active
- 2012-11-30 CA CA2857666A patent/CA2857666C/en active Active
- 2012-11-30 JP JP2014544964A patent/JP6325452B2/ja active Active
- 2012-11-30 ES ES12854165T patent/ES2728445T3/es active Active
- 2012-11-30 AU AU2012345645A patent/AU2012345645B2/en active Active
- 2012-11-30 WO PCT/US2012/067483 patent/WO2013082558A1/en active Application Filing
- 2012-11-30 KR KR1020147018356A patent/KR101999299B1/ko active IP Right Grant
- 2012-11-30 US US14/362,298 patent/US10023848B2/en active Active
- 2012-11-30 RS RS20190664A patent/RS58919B1/sr unknown
- 2012-11-30 SI SI201231603T patent/SI2785368T1/sl unknown
- 2012-11-30 LT LTEP12854165.3T patent/LT2785368T/lt unknown
-
2019
- 2019-05-16 HR HRP20190907TT patent/HRP20190907T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RS58919B1 (sr) | 2019-08-30 |
| CA2857666C (en) | 2020-08-11 |
| US20140308291A1 (en) | 2014-10-16 |
| ES2728445T3 (es) | 2019-10-24 |
| KR101999299B1 (ko) | 2019-07-12 |
| EP2785368A4 (en) | 2015-12-30 |
| KR20140117381A (ko) | 2014-10-07 |
| LT2785368T (lt) | 2019-06-10 |
| EP2785368B1 (en) | 2019-03-13 |
| SI2785368T1 (sl) | 2019-08-30 |
| HRP20190907T1 (hr) | 2019-07-12 |
| JP2015505831A (ja) | 2015-02-26 |
| AU2012345645A1 (en) | 2014-06-26 |
| NZ626762A (en) | 2016-07-29 |
| EP2785368A1 (en) | 2014-10-08 |
| JP6325452B2 (ja) | 2018-05-16 |
| CA2857666A1 (en) | 2013-06-06 |
| US10023848B2 (en) | 2018-07-17 |
| AU2012345645B2 (en) | 2017-09-07 |
| WO2013082558A1 (en) | 2013-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2785368T3 (da) | Immunogen sammensætning, der omfatter panton-valentine-leukocidin (pvl)-afledte polypeptider | |
| DK3401402T3 (da) | Ligander, der er modificeret ved cirkulær permutation, som agonister og antagonister | |
| DK2714735T3 (da) | Antistoffer, der er specifikke for TGF-beta | |
| DK2883402T3 (da) | Downlink-dækningsforbedringer | |
| DK2928495T3 (da) | Sammensætninger, der omfatter anti-cd38-antistoffer og lenalidomid | |
| DK3050134T3 (da) | Fotoaktivt, organisk materiale til optoelektroniske komponenter | |
| DE102013108016A8 (de) | Sicherheitshülle | |
| FI20125839A (fi) | Kasvatussäiliö | |
| DK3513806T5 (da) | Immunogen sammensætning | |
| BR112014009802A2 (pt) | composições de bismaleimida contendo nanossílica | |
| HK1211842A1 (en) | Leave-on compositions containing cellulose materials | |
| DK3421092T3 (da) | Anti-regurgationssammensætning, der bevarer tarmmotiliteten | |
| DK2539323T3 (da) | Fobindelser som Bradykinin-B1-antagonister | |
| BR112013010257A2 (pt) | máquina de biocarvão | |
| DK2732707T3 (da) | Fremgangsmåde til fremstilling af en sammensætning indeholdende caseinomacropeptid | |
| DK2894209T3 (da) | Fremgangsmåde til påfyldning af blandet kølemiddel, der indeholder 2,3,3,3-tetrafluorpropen | |
| DK2851075T3 (da) | Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat | |
| DK3441474T3 (da) | Farmaceutiske sammensætninger indeholdende et muteret leukocidin e | |
| IT1403537B1 (it) | Composizione deodorante. | |
| DK2877156T3 (da) | Chondroitinkomplekser til transkutan absorption | |
| DK2922571T3 (da) | Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyriner | |
| FI20126365A (fi) | Konttilukko | |
| BR112012029459A2 (pt) | um conjunto de embalagem | |
| DK2934147T3 (da) | Sammensætninger, der omfatter en triazolforbindelse | |
| FI9758U1 (fi) | Astia bitumimateriaalien pakkaamiseksi |